Apollo Hospitals, led by 93-year-old founder Dr. Prathap Reddy, reported a 34% increase in Q1 FY27 profit to ₹580 crore. The company is now focusing on the planned demerger of its digital and pharmacy unit, Apollo HealthCo, expected by Q4 FY27.
At the age of 93, Dr. Prathap Chandra Reddy continues to actively lead Apollo Hospitals, the healthcare giant he established over four decades ago. His firm, which now manages a network of over 70 hospitals with more than 10,000 beds, currently commands a market capitalization of approximately ₹1.25 trillion. This consistent leadership comes at a time when the company is delivering strong financial results and preparing for a major structural change.
In its recently reported financial results for the first quarter of fiscal year 2027, Apollo Hospitals posted a consolidated net profit of ₹580 crore. This marks a 34% growth compared to the same period last year and surpassed market expectations, which had anticipated a profit closer to ₹553 crore. This performance highlights the company’s ability to generate revenue even as it invests heavily in expanding its hospital capacity.
Strategic Focus on HealthCo
The most significant upcoming event for investors is the planned separation of the company’s digital health and pharmacy business, known as Apollo HealthCo. The management has targeted a demerger and a separate listing for this entity by the fourth quarter of the 2027 fiscal year. This move is designed to separate the asset-heavy hospital business from the faster-growing, tech-enabled pharmacy and diagnostics operations, allowing each to focus on its specific growth strategy. Investors are watching this closely, as it aims to unlock value by giving the pharmacy and digital business a distinct identity.
Competition and Sector Risks
While the company continues to expand, it operates in a highly competitive sector. Apollo faces stiff competition from major players like Manipal Hospitals, Fortis Healthcare, and Max Healthcare. These competitors are also aggressively expanding their bed capacities, which puts pressure on market share and operational costs.
Beyond competition, the broader healthcare sector is facing increased scrutiny from regulators and the public regarding the affordability of medical services and ethical billing practices. Maintaining high margins while balancing the need for compassionate, accessible patient care remains a persistent challenge for the entire industry. Apollo’s ability to manage these costs during its ongoing expansion will be critical.
The next major milestone for shareholders will be the progress on the Apollo HealthCo demerger process. Investors will also be tracking how the company maintains its profit margins while absorbing the financial costs of building new hospital units and scaling its digital pharmacy network in an increasingly price-conscious market.